Ashraf Eassa
Long/short equity, contrarian, independent research, tech

Applied Micro: Waking Up From The X-Gene Dream

In my previous article, "Applied Micro's Bullish Thesis Ignores Significant Structural Problems", I argued that the shares of Applied Micro (NASDAQ:AMCC) remained highly overvalued in light of what I believe to be unrealistic valuations of the core connectivity and computing businesses. Further, I believe that the company's oft-touted X-Gene system-on-chip targeted at datacentre applications faces extreme competition from both Intel (NASDAQ:INTC) as well as the incoming flood of other players in the ARM (NASDAQ:ARMH) ecosystem. However, in digging through the conference call transcript, as well as some incremental datapoints, I become materially more bearish on Applied Micro's X-Gene prospects.

Why Would Anybody Buy X-Gene Version 1?

On the most recent call, Applied...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details